On January 11, 2021, Bruker Corporation stated that it currently expects revenue for the fourth quarter of fiscal year 2020 in the range of $620-$625 million, including an approximate 4.5% favorable impact from foreign currency translation, during its scheduled presentation at the 39th Annual J.P. Morgan Healthcare Conference.